Surgical Innovations Group PLC Director/PDMR Shareholding (7998K)

TIDMSUN

RNS Number : 7998K

Surgical Innovations Group PLC

09 May 2022

Surgical Innovations Group plc

("Surgical Innovations", "SI" or the "Company")

Director/PDMR Shareholding

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), was notified on the 6 May 2022 that on 26 April 2022 Michael McMahon, Non-Executive Director, purchased 449,333 of shares in Surgical Innovations (the "Ordinary Shares") at a price of 2.22 pence per share.

Following this transaction, Michael McMahon has a combined beneficial holding in the Company of 19,430,962 Ordinary Shares, representing approximately 2.08% of the issued share capital of the Company.

For further information please contact:

 
Surgical Innovations Group plc         www sigroupplc com 
David Marsh, CEO                       Tel: [phone] 
Charmaine Day, CFO 
 
Singer Capital Markets (Nominated Adviser         Tel: [phone] 
 & Broker) 
Aubrey Powell / Rachel Hayes 
 
Walbrook PR (Financial PR & Investor       Tel: [phone] or [e-mail] 
 Relations) 
Paul McManus / Lianne Applegarth       Mob: [phone] 
                                        303 
 
 
 
1   Details of the person discharging managerial responsibilities/person 
     closely associated 
a)  Name                          Michael McMahon 
2   Reason for the notification 
a)  Position/status               Non-Executive Director 
b)  Initial notification/         Initial Notification 
     Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                          Surgical Innovations Group plc 
b)  LEI                           2138004GHGUH3HUZE156 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
 
 
a)   Description of the financial   Ordinary shares of 1p 
      instrument, type of            GB0004016704 
      instrument 
      Identification code 
b)   Nature of the transactions     Transfer of Ordinary Shares 
c)   Price(s) and volume(s)          Price(s)            Volume(s) 
   2.22 pence per 
    share                                                449,333 
 
d)   Aggregated information         224,575 @ 2.2213p 
      - Aggregated volume            224,758 @ 2.2195 p 
      - Price 
e)   Date of the transaction        26 April 2022 
f)   Place of the transaction       London Stock Exchange, AIM 
 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.

Further information

Further details of the Group's businesses and products are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

To receive regular updates by email, please contact [e-mail]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDUIXGDGDC

(END) Dow Jones Newswires

May 09, 2022 13:13 ET (17:13 GMT)